Abstract
Spastic Paraplegia-79 (SPG79) is an autosomal recessive type of childhood onset complicated by hereditary spastic paraplegia. SPG79 is characterized by spasticity, paraplegia, optic atrophy, cerebellar signs, and other variable clinical features. Recessive, disease causing variants in Ubiquitin C-terminal hydrolase-L1 (UCHL1) gene have been implicated as a cause for SPG79 in two families till now. In this study, we report on a third family of SPG79 with two similarly affected siblings, harboring a novel homozygous splice-site variant in the UCHL1 gene (NM_004181.4: c.459+2T>C). The variant was identified by whole-exome sequencing and validated by Sanger sequencing in the family.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Rydning SL, Backe PH, Sousa MML, Iqbal Z, Oye A-M, Sheng Y, et al. Novel UCHL1mutations reveal new insights into ubiquitin processing. Hum Mol Genet. 2017;26:1031–40.
Bilguvar K, Tyagi NK, Ozkara C, Tuysuz B, Bakircioglu M, Choi M, et al. Recessive loss of function of the neuronal ubiquitin hydrolase UCHL1 leads to early-onset progressive neurodegeneration. Proc Natl Acad Sci USA. 2013;110:3489–94.
Das Bhowmik A, Dalal A. Whole exome sequencing identifies a novel frameshift mutation in GPC3 gene in a patient with overgrowth syndrome. Gene. 2015;572:303–6.
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.
Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.
Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science. 1989;246:670–2.
Doran JF, Jackson P, Kynoch P, Thompson RJ. Isolation of PGP 9.5, a new human neurone-specific protein detected by high resolution two-dimensional electrophoresis. J Neurochem. 1983;40:1542–7.
Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCHL1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson’s disease susceptibility. Cell. 2002;111:209–18.
Osaka H, Wang Y-L, Takada K, Takizawa S, Setsuie R, Li H, et al. Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet. 2003;12:1945–58.
Zhang M, Cai F, Zhang S, Zhang S, Song W. Overexpression of ubiquitin carboxyl terminal hydrolase L1 (UCHL1) delays Alzheimer’s progression in vivo. Sci Rep. 2014;4:7298.
Ragland M, Hutter C, Zabetian C, Edwards K. Association between the ubiquitin carboxyl-terminal esterase L1 gene (UCHL1) S18Y variant and Parkinson’s disease: a HuGE review and metaanalysis. Am J Epidemiol. 2009;170:1344–57.
Liu Y, Chen YY, Liu H, Yao CJ, Zhu XX, Chen DJ, et al. Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson’s disease: the impact of ethnicity and onset age. Neurol Sci. 2015;36:179–88.
Butterfield DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, et al. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease:an initial assessment. J Alzheimers Dis. 2006;10:391–7.
Chen F, Sugiura Y, Myers KG, Liu Y, Lin W. Ubiquitin carboxyl-terminal hydrolase L1 is required for maintaining the structure and function of the neuromuscular junction. Proc Natl Acad Sci USA. 2010;107:1636–41.
Acknowledgements
We thank the families who cooperated with the evaluation of the subjects and consented for participation in this study.
Funding
This work was supported by Science and Engineering Research Board (SERB), Government of India (SERB file no. YSS/2015/001681).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Das Bhowmik, A., Patil, S.J., Deshpande, D.V. et al. Novel splice-site variant of UCHL1 in an Indian family with autosomal recessive spastic paraplegia-79. J Hum Genet 63, 927–933 (2018). https://doi.org/10.1038/s10038-018-0463-6
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s10038-018-0463-6
This article is cited by
-
Investigating the genetic basis of hereditary spastic paraplegia and cerebellar Ataxia in Pakistani families
BMC Neurology (2024)
-
Phenotypic variability related to dominant UCHL1 mutations: about three families with optic atrophy and ataxia
Journal of Neurology (2024)
-
Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons
Gene Therapy (2022)
-
Challenges and Controversies in the Genetic Diagnosis of Hereditary Spastic Paraplegia
Current Neurology and Neuroscience Reports (2021)
-
Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion
Journal of Neurology (2020)
